Robinhood Markets is entering a quiet stretch after its post-earnings bruising, with short sellers pulling back meaningfully — but options traders sending a fresh note of caution.
The clearest shift this week is in short positioning. Shorts have been retreating steadily since early August. SI dropped roughly 10% over the week to 4.3% of the free float — down from above 5% in early July when sellers were at their most aggressive. That's a meaningful unwind. The direction of travel is unambiguous: over the past month shorts have cut exposure by around 15%, trimming from roughly 40 million shares to 33.7 million. The borrow market echoes this mood. Cost to borrow has slipped to just 0.39% — near its lowest level in the 30-day window — and availability is extremely loose at around 1,188% of short interest. Over 476 million shares remain available to lend. There is no pressure in the lending market whatsoever.
Options tell a different story. The put/call ratio has jumped to 0.67, running more than two standard deviations above its 20-day average — the highest defensive skew in recent months. That's unusual for a stock where the ratio has been tightly clustered around 0.64 for most of July. Options traders appear to be hedging into the stock's next move even as short sellers are stepping back. Those two signals don't point in the same direction, and that tension is worth watching. The divergence is relatively fresh — the PCR only broke higher on August 11 — and it arrived the same day SI posted its sharpest one-day drop of the week.
The Street remains bullish in aggregate, but with a notable trim on ambition. As noted in the previous note from August 5, every major firm that moved after the July 29 earnings print went lower on its target while keeping its positive rating. That picture hasn't changed. Goldman Sachs holds Buy at $118, Barclays holds Overweight at $105, Cantor Fitzgerald maintains Overweight at $115. The consensus mean of $119.82 implies roughly 27% upside from the current $94.38 close — a gap that has narrowed only marginally since earnings resolved nothing on the valuation question. Factor scores support the constructive read: EPS momentum ranks in the 96th percentile on a 90-day basis, and the analyst recommendation differential sits in the 91st percentile. The P/E multiple has pulled back around 8 points over the past 30 days to 32.5x, reflecting the stock's 16% decline over the month.
Insider activity is worth flagging, though not alarming. The Chief Legal Officer sold roughly $904,000 worth of shares on August 3 across six small tranches. Co-founder Baiju Bhatt sold just over $2.8 million on July 24. Both Vladimir Tenev and Bhatt have reduced their registered positions modestly in recent filings. Net insider activity over the 90-day window is technically positive at around 448,000 shares, so the overall picture is one of routine trimming rather than coordinated exit. On the institutional side, BlackRock added 4.3 million shares as of July 31, while Amundi added 3.1 million as of July 30 — flows that suggest continued passive and active demand at these levels.
The next scheduled earnings event isn't until November 4, leaving the stock in a data-light period where price direction will likely be driven by the resolution of the current tension: whether the options hedging reflects genuine concern about Robinhood's near-term trajectory or simply post-earnings noise unwinding at a different pace than the short book.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
